Inventor · disambiguated record
Matthew Isherwood
Also filed as: ISHERWOOD MATTHEW · ISHERWOOD MATTHEW L
9 granted patents·4 pending applications·39 citations·filing 2006–2015
84Inventor score
Files withBRISTOL MYERS SQUIBB CO4ALBANY MOLECULAR RES INC2GUZZO PETER R2AMR TECHNOLOGY INC1IOMET PHARMA LTD1
Top patents by PatentIndex Score
13 records- 0188US7956050B2Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninALBANY MOLECULAR RES INC·Filed 2006·Granted Jun 7, 2011·13 cites·28 claims
- 0287US8445494B2Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amineQIU JUN·Filed 2009·Granted May 21, 2013·11 cites·1 claims
- 0384US8420811B2Tetrahydroisoquinolines and intermediates thereforLOBBEN PAUL·Filed 2009·Granted Apr 16, 2013·11 cites·2 claims
- 0482US9156812B2Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amineBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Oct 13, 2015·3 cites·7 claims
- 0569US8791101B2Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninMOLINO BRUCE F·Filed 2010·Granted Jul 29, 2014·1 cites·34 claims
- 0663US2009118260A1Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninAMR TECHNOLOGY INC·Filed 2008·Application pending·0 cites
- 0759US9403776B2Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotoninALBANY MOLECULAR RES INC·Filed 2014·Granted Aug 2, 2016·0 cites·14 claims
- 0856US9498476B2Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amineBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Nov 22, 2016·0 cites·2 claims
- 0956US2013060027A1Tetrahydroisoquinolines and intermediates thereforBRISTOL MYERS SQUIBB CO·Filed 2012·Application pending·0 cites
- 1049US2015191494A1Tetrahydroisoquinolines and intermediates thereforBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 1140US2016120863A1Slc2a transporter inhibitorsIOMET PHARMA LTD·Filed 2014·Application pending·0 cites
- 1232US9067949B2Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophreniaGUZZO PETER R·Filed 2012·Granted Jun 30, 2015·0 cites·52 claims
- 1330US8575186B2Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereofGUZZO PETER R·Filed 2010·Granted Nov 5, 2013·0 cites·53 claims
Join the waitlist — get patent alerts
Get an alert when Matthew Isherwood files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →